drugset / Trial / NCT04347473
ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.
Phase 4
Recruiting
25 enrolled
Psoriasis Treatment Center of Central New Jersey
Sun Pharmaceutical Industries, Inc. · collab
NaSingle-groupOpen-labelTreatment
Summary
Patient with moderate-to-severe plaque psoriasis will receive Ilumya with or without Halog ointment.
Timeline
- Start
- 2020-04-06
- Primary completion
- 2020-12-30
- Completion
- 2021-03-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tildrakizumab | Monoclonal antibody | 100 mg | Subcutaneous |